Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial
出版年份 2015 全文链接
标题
Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial
作者
关键词
-
出版物
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Volume 18, Issue 5, Pages 357-368
出版商
Informa UK Limited
发表日期
2015-12-22
DOI
10.3109/15622975.2015.1117654
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine
- (2015) Akiko Matsuura et al. ACTA NEUROPSYCHIATRICA
- Clinical and Electrophysiological Effects of D-Serine in a Schizophrenia Patient Positive for Anti-N-Methyl-D-Aspartate Receptor Antibodies
- (2015) Uriel Heresco-Levy et al. BIOLOGICAL PSYCHIATRY
- Behavioral and cognitive effects of the N-methyl-d-aspartate receptor co-agonist d-serine in healthy humans: Initial findings
- (2015) Raz Levin et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine
- (2015) Akiko Matsuura et al. ACTA NEUROPSYCHIATRICA
- Assessing and Treating Cognitive Impairment in Schizophrenia: Current and Future
- (2014) Chun-Yuan Lin et al. CURRENT PHARMACEUTICAL DESIGN
- Targeting of NMDA receptors in new treatments for schizophrenia
- (2014) Kenji Hashimoto EXPERT OPINION ON THERAPEUTIC TARGETS
- Normalizing Effects of EVP-6124, an Alpha-7 Nicotinic Partial Agonist, on Event-Related Potentials and Cognition
- (2014) SHELDON H. PRESKORN et al. Journal of Psychiatric Practice
- Chronic D-serine reverses arc expression and partially rescues dendritic abnormalities in a mouse model of NMDA receptor hypofunction
- (2014) Darrick T. Balu et al. NEUROCHEMISTRY INTERNATIONAL
- Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment
- (2014) A. McCleery et al. SCHIZOPHRENIA RESEARCH
- Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia
- (2014) Daniel Umbricht et al. JAMA Psychiatry
- Benzoate, a D-Amino Acid Oxidase Inhibitor, for the Treatment of Early-Phase Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2013) Chieh-Hsin Lin et al. BIOLOGICAL PSYCHIATRY
- Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
- (2013) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Decreased levels of d-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia
- (2013) Francesco Errico et al. JOURNAL OF PSYCHIATRIC RESEARCH
- NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
- (2013) Pierre Paoletti et al. NATURE REVIEWS NEUROSCIENCE
- Synergistic Effects of COMT and TPH2 on Social Cognition
- (2013) Chieh-Hsin Lin et al. PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES
- Update on Typical and Atypical Antipsychotic Drugs
- (2012) Herbert Y. Meltzer Annual Review of Medicine
- Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists
- (2012) Thomas Papouin et al. CELL
- A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
- (2012) Mark Weiser et al. JOURNAL OF CLINICAL PSYCHIATRY
- Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
- (2012) Mark J. Millan et al. NATURE REVIEWS DRUG DISCOVERY
- Feasibility, Safety and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study
- (2012) Deepak C D'Souza et al. NEUROPSYCHOPHARMACOLOGY
- Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
- (2012) D. C. Javitt et al. SCHIZOPHRENIA BULLETIN
- Impact of Neurocognition on Social and Role Functioning in Individuals at Clinical High Risk for Psychosis
- (2011) Ricardo E. Carrión et al. AMERICAN JOURNAL OF PSYCHIATRY
- Evaluation of Functionally Meaningful Measures for Clinical Trials of Cognition Enhancement in Schizophrenia
- (2011) Michael F. Green et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of low-dose d-serine on recognition and working memory in mice
- (2011) Patricia Bado et al. PSYCHOPHARMACOLOGY
- Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood–brain barrier integrity
- (2011) Johann Steiner et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- International Consensus Study of Antipsychotic Dosing
- (2010) David M. Gardner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
- (2010) Guochuan Tsai et al. CURRENT PHARMACEUTICAL DESIGN
- Reliability and validity of three Chinese-version tasks of Mayer-Salovey-Caruso Emotional Intelligence Test
- (2010) Wei-Fen Ma et al. JOURNAL OF CLINICAL NURSING
- d-Amino acid oxidase knockdown in the mouse cerebellum reduces NR2A mRNA
- (2010) Philip W.J. Burnet et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- High dose D-serine in the treatment of schizophrenia
- (2010) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- The MCCB impairment profile for schizophrenia outpatients: Results from the MATRICS psychometric and standardization study
- (2010) Robert S. Kern et al. SCHIZOPHRENIA RESEARCH
- Cognition at illness onset as a predictor of later functional outcome in early psychosis: Systematic review and methodological critique
- (2010) Kelly Allott et al. SCHIZOPHRENIA RESEARCH
- Relationships Between Cognitive Deficits, Symptoms and Quality of Life in Schizophrenia
- (2009) Kara Savilla et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Cortical Development and Glutamatergic Dysregulation in Schizophrenia
- (2009) Akira Sawa BIOLOGICAL PSYCHIATRY
- Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine
- (2009) Kenji Hashimoto et al. BIOLOGICAL PSYCHIATRY
- A randomized, double-blind, placebo-controlled comparison study of sarcosine ( N-methylglycine) and d-serine add-on treatment for schizophrenia
- (2009) Hsien-Yuan Lane et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Reduces Microglial and Astroglial Inflammatory Responses
- (2009) S. Brahmachari et al. JOURNAL OF IMMUNOLOGY
- The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
- (2009) L Verrall et al. MOLECULAR PSYCHIATRY
- The involvement of the NMDA receptor d-serine/glycine site in the pathophysiology and treatment of schizophrenia
- (2009) Viviane Labrie et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Relationship of Cognition and Psychopathology to Functional Impairment in Schizophrenia
- (2008) Somaia Mohamed et al. AMERICAN JOURNAL OF PSYCHIATRY
- The MATRICS Consensus Cognitive Battery, Part 2: Co-Norming and Standardization
- (2008) Robert S. Kern et al. AMERICAN JOURNAL OF PSYCHIATRY
- Glycine Transport Inhibitors and the Treatment of Schizophrenia
- (2008) Daniel C. Javitt BIOLOGICAL PSYCHIATRY
- Sarcosine (N-Methylglycine) Treatment for Acute Schizophrenia: A Randomized, Double-Blind Study
- (2007) Hsien-Yuan Lane et al. BIOLOGICAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started